0 Comentários
0 Compartilhamentos
696 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Antibodies Market Advances with Growing Demand for Precision MedicineThe Antibodies Market is projected to grow from USD 256.1 billion in 2026 to USD 489.8 billion by 2036 at a 6.7% CAGR. ROCKVILLE, MD — October 6, 2026 — The Antibodies Market is projected to reach USD 489.8 billion by 2036, rising from USD 256.1 billion in 2026 at a CAGR of 6.7%, according to Fact.MR. The market was valued at approximately USD 240.0 billion in 2025 and is expected...0 Comentários 0 Compartilhamentos 37 Visualizações 0 Anterior
-
ASEAN Non-Invasive Radiosurgery Robots Market to Grow at 8.9% CAGR by 2033Non-invasive radiosurgery robots are advanced medical systems that use robotic technology, imaging guidance, and precisely targeted radiation to treat tumors and other medical conditions without the need for conventional surgery or surgical incisions. The ASEAN Non-Invasive Radiosurgery Robots Market is projected to grow from US$ 18.0 million in 2025 to US$ 35.8 million by 2033,...0 Comentários 0 Compartilhamentos 177 Visualizações 0 Anterior
-
ASEAN Non-Invasive Radiosurgery Robots Market to Grow at 8.9% CAGR by 2033Non-invasive radiosurgery robots are advanced medical systems that use robotic technology, imaging guidance, and precisely targeted radiation to treat tumors and other medical conditions without the need for conventional surgery or surgical incisions. The ASEAN Non-Invasive Radiosurgery Robots Market is projected to grow from US$ 18.0 million in 2025 to US$ 35.8 million by 2033,...0 Comentários 0 Compartilhamentos 144 Visualizações 0 Anterior
-
Latin America Cancer Chemotherapy Market to Grow at a CAGR of 9.1% During 2025–2031Cancer chemotherapy is a systemic treatment that uses specialized drugs to destroy cancer cells, prevent their growth, or slow their spread throughout the body. By targeting rapidly dividing cells, chemotherapy plays a vital role in treating many forms of cancer, including lung, breast, colorectal, blood, prostate, stomach, cervical, and ovarian cancers. It continues to be one of the most...0 Comentários 0 Compartilhamentos 272 Visualizações 0 Anterior
-
Middle East Cancer Radiation Therapy Market to Reach US$ 1,243.7 Million by 2031 at a CAGR of 10.2%Cancer radiation therapy is a widely used cancer treatment that employs high-energy radiation, such as X-rays, gamma rays, electron beams, or protons, to destroy cancer cells and inhibit their growth. The treatment works by damaging the DNA of cancer cells, preventing them from multiplying while preserving healthy surrounding tissues through advanced precision-based technologies....0 Comentários 0 Compartilhamentos 288 Visualizações 0 Anterior
-
Nordic Non-Invasive Radiosurgery Robots Market to Expand at 3.6% CAGR from 2026 to 2033The Nordic Non-Invasive Radiosurgery Robots Market covers advanced medical robotic systems used to deliver highly targeted radiation treatment across Sweden, Denmark, Norway, and Finland. These technologies enable doctors to treat tumors and certain neurological disorders without conventional open surgery. By combining robotic positioning, advanced imaging, treatment...0 Comentários 0 Compartilhamentos 94 Visualizações 0 Anterior
-
Nordic Non-Invasive Radiosurgery Robots Market to Expand at 3.6% CAGR from 2026 to 2033Nordic non-invasive radiosurgery robots are advanced medical systems used across Sweden, Denmark, Norway, and Finland to deliver highly accurate radiation treatment without the need for traditional open surgery. These technologies combine robotic positioning, advanced imaging, computerized treatment planning, and precision radiation delivery to target tumors and other medical...0 Comentários 0 Compartilhamentos 106 Visualizações 0 Anterior
-
North America Cancer Hormone Therapy Market to Grow at a CAGR of 12.1% During 2025–2031Cancer hormone therapy, also known as endocrine therapy, is a targeted treatment that helps control the growth of hormone-dependent cancers by either lowering hormone levels in the body or preventing hormones from stimulating cancer cells. It is commonly prescribed for patients with breast, prostate, endometrial, ovarian, and thyroid cancers, where hormones play a significant role in disease...0 Comentários 0 Compartilhamentos 283 Visualizações 0 Anterior
-
Palonosetron Market Expected to Expand at 4.4% CAGR Amid Rising Need for Effective CINV ManagementAccording to a new report from Intel Market Research, the global Palonosetron market was valued at USD 110 million in 2024 and is projected to reach USD 148 million by 2034, growing at a CAGR of 4.4% during the forecast period (2025–2034). This growth is fueled by rising cancer incidence globally and increasing adoption of chemotherapy protocols requiring effective antiemetic solutions....0 Comentários 0 Compartilhamentos 228 Visualizações 0 Anterior
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek
Bengali